ReviewClinical pharmacokinetics2011

Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on 4-anilinoquinazolines.

Matthias Scheffler et al.PubMed ↗Publisher ↗

No numbers read from the abstract.